Showing results (181-190 of 195) with videos related to
Sort By:
Pageof 20
Transboundary and Emerging Diseases|April 30, 2025
Effectiveness of Passive and Active Surveillance for Early Detection of SARS-CoV-2 in Mink during the 2020 Outbreak in the NetherlandsInge M G A Santman-Berends, Gerdien van Schaik, Marieke Augustijn-Schretlen, et al.Viruses|August 26, 2022
Manifestation of SARS-CoV-2 Infections in Mink Related to Host-, Virus- and Farm-Associated Factors, The Netherlands 2020Wendy J Wolters, Myrna M T de Rooij, Robert Jan Molenaar, et al.Hemasphere|July 15, 2026
Risk of thrombosis and bleeding following CAR T-cell therapy: Insights from the Dutch "Follow that CAR!" registryAmica K Ko, Pim G N J Mutsaers, Lukas M van Kleij, et al.Science (New York, N.Y.)|November 11, 2020
Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humansBas B Oude Munnink, Reina S Sikkema, David F Nieuwenhuijse, et al.Cancers|September 9, 2023
The Dutch CAR-T Tumorboard Experience: Population-Based Real-World Data on Patients with Relapsed or Refractory Large B-Cell Lymphoma Referred for CD19-Directed CAR T-Cell Therapy in The NetherlandsAnne M Spanjaart, Elise R A Pennings, Pim G N J Mutsaers, et al.Blood Advances|September 11, 2020
Ibrutinib added to 10-day decitabine for older patients with AML and higher risk MDSGerwin Huls, Dana A Chitu, Thomas Pabst, et al.Transboundary and Emerging Diseases|June 3, 2021
SARS-CoV-2 infection in cats and dogs in infected mink farmsAnna E van Aart, Francisca C Velkers, Egil A J Fischer, et al.Leukemia|July 22, 2022
Addition of the nuclear export inhibitor selinexor to standard intensive treatment for elderly patients with acute myeloid leukemia and high risk myelodysplastic syndromeJ J W M Janssen, B Löwenberg, M Manz, et al.Nature Communications|November 24, 2021
Adaptation, spread and transmission of SARS-CoV-2 in farmed minks and associated humans in the NetherlandsLu Lu, Reina S Sikkema, Francisca C Velkers, et al.Blood Cancer Journal|June 19, 2023
Age and sex associate with outcome in older AML and high risk MDS patients treated with 10-day decitabineJacobien R Hilberink, Isabelle A van Zeventer, Dana A Chitu, et al.Pageof 20